CCL28 and CCL27 participate in the anticancer response of the immune system, causing an infiltration of the tumor by anticancer NK cells, which leads to improved prognosis with an increased expression of these chemokines in the tumor [313,317,318,319]. This evidence concerns the gene CCL27 and neoplasm.